Attached files
| file | filename |
|---|---|
| EX-16.1 - EXHIBIT 16.1 - Hartford Great Health Corp. | ex16x1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 11, 2019
|
|
|
HARTFORD GREAT HEALTH CORP.
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
California
|
|
333-164633
|
|
20-5422795
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
8832 Glendon Way, Rosemead, California
|
|
91770
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
626-321-1915
Registrant's telephone number, including area code
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 4.01 CHANGES IN REGISTRANT' S CERTIFYING ACCOUNTANT
(a) On January 11, 2019, the board of directors of Hartford Great Health Corp. (the "Company") agreed to the resignation of its independent registered public accounting firm, Haynie & Company, Salt Lake City ("Haynie"), effective as of January 11, 2019.
The reports of Haynie on the Company's financial statements for the year ended July 31, 2018 did not contain an adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles, with the exception of providing a qualification as to the Company's ability to continue as a going concern. During the year ended July 31, 2018 and in the subsequent period through Haynie's resignation, there were no disagreements with Haynie on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which if not resolved to the satisfaction of Haynie, would have caused Haynie to make reference to the matter in its reports on the Company's financial statements for such periods.
The Company provided Haynie with a copy of the disclosures in the preceding paragraph and requested in writing that Haynie furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not they agree with such disclosures. Haynie provided a letter, dated January 16, 2019 stating its agreement with such statements, which is included as exhibit 16.1 to this Current Report on Form 8-K.
(b) On January 16, 2019, the Company, based on the decision of its board of directors, approved the engagement of Simon & Edward, Diamond Bar, California ("S&E") to serve as the Company's independent registered public accounting firm, commencing January 16, 2019.
During the fiscal year ended July 31, 2018 and through the date of the board of directors' decision, the Company did not consult S&E with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's consolidated financial statements, or any other matter or reportable events listed in Items 304(a)(2)(i) and (ii) of Regulation S-K.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
HARTFORD GREAT HEALTH CORP.
|
|
|
|
|
|
|
|
|
|
Dated: January 16, 2019
|
|
By: /s/ Sheng-Yih Chang
|
|
|
|
Sheng-Yih Chang
|
|
|
|
Chief Financial Officer
|